HCS Pharma is pleased to present the whole range of BIOMIMESYS® Products.

All our scientific team is ready to support you in using our 3D organ/tissue-specific cell-culture technology.

Rediscover your cells in real in vitro 3D-culture conditions with our special evaluation plate format .

You can find our presentation in PDF format with this link

For more information, contact us at hello@biomimesys.com

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

1 Comment

New 384-well plates format for BIOMIMESYS® Liver & Oncology entitling Cell-Based Assays High-Throughput Screening | HCS Pharma · November 26, 2020 at 2:01 pm

[…] BIOMIMESYS® 3D cell culture systems and obtain more predictive in vitro […]

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.